Macular Degeneration
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-06-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:27
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Macular Degeneration Formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina.
DOSAGE & ADMINISTRATION SECTION
Directions: ORAL USE ONLY - SHAKE WELL. Ages 12 and up, take 6 drops orally one to four times daily or as directed by a healthcare professional.
ACTIVE INGREDIENT SECTION
Elaps corallinus 30x, Aconitum nap. 15x, Aur. met. 15x, Baryta carb. 15x, Belladonna 15x, Crotalus horridus 15x, Gelsemium 15x, Hamamelis 15x, Lachesis 15x, Merc. viv. 15x, Phosphorus 15x, Picricum ac. 15x, Plumbum met. 15x, Pulsatilla 15x, Rhus toxicodendron 15x, Stramonium 15x, Theridion 15x, Euphrasia 3x.
PURPOSE SECTION
Formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: USP Purified Water; USP Gluten-free, non-GMO, organic cane dispensing alcohol 20%.
QUESTIONS? SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-4598-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-769c-f424-e053-dadaa90a57ce | Macular Degeneration |
| 55714-4598-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-769c-f424-e053-dadaa90a57ce | Macular Degeneration |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-4598-1 | Macular Degeneration | 29.57 mL in 1 BOTTLE, GLASS | LIQUID | 29.57 | 3 | |
| 55714-4598-2 | Macular Degeneration | 59.14 mL in 1 BOTTLE, GLASS | LIQUID | 59.14 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-4598 | MACULAR DEGENERATION (ELAPS CORALLINUS, ACONITUM NAP.,AUR. MET., BARYTA CARB., BELLADONNA, CROTALUS HORRIDUS, GELSEMIUM, HAMAMELIS, LACHESIS, MERC. VIV.,PHOSPHORUS, PICRICUM AC., PLUMBUM MET., PULSATILLA,RHUS TOXICODENDRON, STRAMONIUM, THERIDION, EUPHRASIA) LIQUID [NEWTON LABORATORIES, INC.] | 3 | Legacy NDC, 2 package rows | 20140211_5b025376-4ecd-8422-6a4e-2f759bd06240.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 3 | |
| Atropa Belladonna | ACTIVE INGREDIENT | WQZ3G9PF0H | 3 | |
| Barium Carbonate | ACTIVE INGREDIENT | 6P669D8HQ8 | 3 | |
| Crotalus Horridus Horridus Venom | ACTIVE INGREDIENT | YHA2XLJ956 | 3 | |
| Datura Stramonium | ACTIVE INGREDIENT | G6W4F0V8Z3 | 3 | |
| Euphrasia Stricta | ACTIVE INGREDIENT | C9642I91WL | 3 | |
| Gelsemium Sempervirens Root | ACTIVE INGREDIENT | 639KR60Q1Q | 3 | |
| Gold | ACTIVE INGREDIENT | 79Y1949PYO | 3 | |
| Hamamelis Virginiana Root Bark/stem Bark | ACTIVE INGREDIENT | T7S323PKJS | 3 | |
| Lachesis Muta Venom | ACTIVE INGREDIENT | VSW71SS07I | 3 | |
| Lead | ACTIVE INGREDIENT | 2P299V784P | 3 | |
| Mercury | ACTIVE INGREDIENT | FXS1BY2PGL | 3 | |
| Micrurus Corallinus Venom | ACTIVE INGREDIENT | V0S6H36980 | 3 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 3 | |
| Picric Acid | ACTIVE INGREDIENT | A49OS0F91S | 3 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 3 | |
| Theridion Curassavicum | ACTIVE INGREDIENT | 9Z8D3HEM8L | 3 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 3 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 3 | |
| Atropa Belladonna | ACTIVE MOIETY | WQZ3G9PF0H | 3 | |
| Barium Cation | ACTIVE MOIETY | V645272HLN | 3 | |
| Crotalus Horridus Horridus Venom | ACTIVE MOIETY | YHA2XLJ956 | 3 | |
| Datura Stramonium | ACTIVE MOIETY | G6W4F0V8Z3 | 3 | |
| Euphrasia Stricta | ACTIVE MOIETY | C9642I91WL | 3 | |
| Gelsemium Sempervirens Root | ACTIVE MOIETY | 639KR60Q1Q | 3 | |
| Gold | ACTIVE MOIETY | 79Y1949PYO | 3 | |
| Hamamelis Virginiana Root Bark/stem Bark | ACTIVE MOIETY | T7S323PKJS | 3 | |
| Lachesis Muta Venom | ACTIVE MOIETY | VSW71SS07I | 3 | |
| Lead | ACTIVE MOIETY | 2P299V784P | 3 | |
| Mercury | ACTIVE MOIETY | FXS1BY2PGL | 3 | |
| Micrurus Corallinus Venom | ACTIVE MOIETY | V0S6H36980 | 3 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 3 | |
| Picric Acid | ACTIVE MOIETY | A49OS0F91S | 3 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 3 | |
| Theridion Curassavicum | ACTIVE MOIETY | 9Z8D3HEM8L | 3 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 3 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 3 |
Products#
Every source-derived product name is available through these pages.
- Macular Degeneration
- Elaps corallinus, Aconitum nap.,Aur. met., Baryta carb., Belladonna, Crotalus horridus, Gelsemium, Hamamelis, Lachesis, Merc. viv.,Phosphorus, Picricum ac., Plumbum met., Pulsatilla,Rhus toxicodendron, Stramonium, Theridion, Euphrasia
- Micrurus Corallinus Venom
- Aconitum Napellus
- Gold
- Barium Carbonate
- Barium Cation
- Atropa Belladonna
- Crotalus Horridus Horridus Venom
- Gelsemium Sempervirens Root
- Hamamelis Virginiana Root Bark/stem Bark
- Lachesis Muta Venom
- Mercury
- Phosphorus
- Picric Acid
- Lead
- Pulsatilla Vulgaris
- Toxicodendron Pubescens Leaf
- Datura Stramonium
- Theridion Curassavicum
- Euphrasia Stricta
- Alcohol
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-4598 | 55714-4598-1, 55714-4598-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c98ecee8-3d53-392a-8a79-459cebd19d1e | 5b025376-4ecd-8422-6a4e-2f759bd06240 | 2011-06-01 | Warnings | c98ecee8-3d53-392a-8a79-459cebd19d1e 5b025376-4ecd-8422-6a4e-2f759bd06240 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
